Loading the content... Loading depends on your connection speed!

Shopping Cart - $0.00

Thyroid Cancer Market Global Briefing 2017

Thyroid Cancer Market Global Briefing 2017

From $1,000.00

Including: Drugs For – Papillary Thyroid Cancer, Follicular Thyroid Cancer, Medullary Thyroid Cancer, Anaplastic Carcinoma, And Thyroid Lymphoma.
Covering: Abbott Laboratories, Pfizer, Genzyme


Clear selection
SKU: 2260. Category: .
Description

Thyroid cancer Market Global Briefing 2017 from The Business Research Company provides the strategists, marketers and senior management with the critical information they need to assess the global thyroid cancer market.

Description

The Thyroid cancer Market Global Briefing Report from The Business Research Company covers market characteristics, size and growth, segmentation, regional breakdowns, competitive landscape, market shares, trends and strategies for this market.

The thyroid cancer market is one of the segments in the oncology drugs market, within the pharmaceutical drugs market.

The market characteristics section of the report defines and explains the market.

The market size section gives the thyroid cancer market revenues, covering both the historic growth of the market and forecasting the future.

Drivers and restraints looks at the external factors supporting and controlling the growth of the market.

Market segmentations break down the key sub sectors which make up the market. The regional breakdowns section gives the size of the market geographically.

Competitive landscape gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in the last three years are identified.

The trends and strategies section highlights the likely future developments in the thyroid cancer market and suggests approaches.

Reasons to Purchase

• Get up to date information available on the thyroid cancer market globally.
• Identify growth segments and opportunities.
• Facilitate decision making on the basis of historic and forecast data and understand the drivers and restraints on the market.
• Develop strategies based on likely future developments.
• Gain a global perspective on the development of the market.
• Report will be updated with the latest data and delivered to you within 2-3 working days of order.

Scope

Markets Covered: Drugs For – Papillary thyroid cancer, Follicular thyroid cancer, Medullary thyroid cancer, Anaplastic carcinoma, and Thyroid lymphoma.

Companies Mentioned: Abbott Laboratories, Pfizer, Genzyme.

Countries: Brazil, China, France, Germany, India, Italy, Japan, Spain, Russia, UK, USA and Australia.

Regions: Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East And Africa

Time series: Five years historic and forecast.

Data: Market value in $ billions.

Data segmentations: Regional breakdowns, market share of competitors, key sub segments.

Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

Related Reports:
Lung cancer Market Global Briefing 2017
Pancreatic cancer Market Global Briefing 2017
Breast cancer Market Global Briefing 2017
Prostate cancer Market Global Briefing 2017
Ovarian cancer Market Global Briefing 2017
Gastric Cancer Market Global Briefing 2017
Non-Small Cell Lung Cancer Market Global Briefing 2017
Brain Tumor Market Global Briefing 2017
Colorectal Cancer Market Global Briefing 2017
Bladder Cancer Market Global Briefing 2017
Kidney Cancer Market Global Briefing 2017
Skin cancer Market Global Briefing 2017
Cervical Cancer Market Global Briefing 2017
Blood cancer Market Global Briefing 2017

Table Of Contents
Table Of Contents

1. Introduction
2. Thyroid cancer Market Characteristics
3. Thyroid cancer Market Historic Growth
• Drivers Of The Market
• Restraints On The Market
4. Thyroid cancer Market Forecast Growth
• Drivers Of The Market
• Restraints On The Market
5. Thyroid cancer Market Geography Split
6. Thyroid cancer Market As A Proportion of Oncology Drugs Market, 2016, By Region
7. Thyroid cancer Market As A Proportion of Oncology Drugs Market, 2016, By Country
8. Thyroid cancer Market Segmentation
9. Thyroid cancer Competitive Landscape
Abbott Laboratories
Pfizer
Genzyme
10. Key Mergers And Acquisitions In The Thyroid cancer Market
11. Thyroid cancer Market Trends And Strategies
Appendix
NAICS Definitions of Industry Covered In This Report
Research Methodology
Methodology
Data
Market Numbers
Competitor Market Share Data
Analysis
Verification Through Expert Interviews
Referencing
Note on Currency Conversions
Abbreviations
Currencies
Research Inquiries
The Business Research Company

List Of Tables
Table 1: Global Thyroid cancer Market Historic Market Size, 2012 – 2016, $ Billion
Table 2: Global Thyroid cancer Market Forecast Market Size, 2016 – 2020, $ Billion
Table 3: Global Thyroid cancer Market, Split By Region, 2016, $ Billion
Table 4: Thyroid cancer Market As A Proportion of Oncology Drugs Market, 2016, By Region
Table 5: Thyroid cancer Market As A Proportion of Oncology Drugs Market, 2016, By Country
Table 6: Global Thyroid cancer Market, Key Competitor Shares, 2016, Percentage (%)
Table 7: Global Thyroid cancer Market, Split By Segments, 2016, $ Billion

List Of Figures
Figure 1: Global Thyroid cancer Market Historic Market Size, 2012 – 2016, $ Billion
Figure 2: Global Thyroid cancer Market Forecast Market Size, 2016 – 2020, $ Billion
Figure 3: Global Thyroid cancer Market, Split By Region, 2016, $ Billion
Figure 4: Thyroid cancer Market As A Proportion of Oncology Drugs Market, 2016, By Region
Figure 5: Thyroid cancer Market As A Proportion of Oncology Drugs Market, 2020, By Country
Figure 6: Global Thyroid cancer Market, Key Competitor Shares, 2016, Percentage (%)
Figure 7: Global Thyroid cancer Market, Split By Segments, 2016, $ Billion
Executive Summary
The thyroid cancer drugs market cover drugs that treat cancer that affect thyroid gland. These indications include Papillary thyroid cancer, Follicular thyroid cancer, Medullary thyroid cancer, Anaplastic carcinoma, and Thyroid lymphoma. Some of the major drugs in this market are Cabozantinib (Cometriq), vandetanib (Caprelsa), sorafenib (Nexavar), lenvatinib mesylate (Lenvima).

The global thyroid cancer market was estimated to be around $0.23 billion as of 2016. The global thyroid cancer made up around 0.2% of the overall oncology drugs market in 2016. The thyroid cancer market was the smallest market in the global oncology drugs market in 2016.

Acquisitions
Acquisition of thyroid cancer business segment or product portfolio from another competitors in this market is an emerging trend in the market. For instance, in July 2015, Genzyme (a subsidiary of Sanofi) announced to acquire AstraZeneca's Caprelsa thyroid cancer drug for approximately $300 million. Caprelsa is used in the treatment of thyroid cancer drugs. Caprelsa is currently available in 28 countries and generated $48 million revenues in 2014.

Product Approval
Product approvals from regulatory bodies such as FDA in the US and EMA in Europe is one of the major trend in this market. For instance, in February 2015, Eisai Co Ltd. received FDA approval for its Lenvima drug that is used in the treatment of differntiated thyroid cancer.
Get Customized Report
Please fill in your details. Our team will get back to you